Opus Genetics, Inc. · NASDAQ:IRD
Foundation Fighting Blindness Retinal Degeneration Fund sold 556,000 Opus Genetics, Inc. shares (Form 4)
Traded Sep 30, 2026 · Filed Oct 2, 2026
On Sep 30, 2026, Foundation Fighting Blindness Retinal Degeneration Fund (Director, See Remarks) sold 556,000 Opus Genetics, Inc. shares at US$4.96 for US$2.76M, leaving 3,236,171 shares. Filed Oct 2, 2026 (Form 4).
- Sold
- 556,000 shares
- Price
- US$4.96
- Value
- US$2.76M
- Holding after
- 3,236,171 shares
- Trading plan
- No
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common Stock | Sale | 556,000 | US$4.96 | 3,236,171 | Direct |
Source
Related
- Opus Genetics, Inc.
- Foundation Fighting Blindness Retinal Degeneration Fund
- Opus Genetics, Inc. shareholders
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · May 20, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026